Comparison of Non-invasive to Invasive Assessment of Jugular Venous Pressure
1 other identifier
observational
20
1 country
1
Brief Summary
Assessment of the jugular venous pressure (JVP) is an important clinical sign and correlates with right atrial (RA) pressure. A patient with heart failure (HF) typically has an elevated JVP, but in cases of dehydration JVP may be low. Assessment of the JVP is key to the management of patients with fluid overload or needing diuretics. Currently the assessment of JVP is made by the physician by direct visualization of the neck veins. However this is inaccurate, may vary between investigators and depends largely on the patient's habitus. The JVP and RA pressures may also be directly measured by catheterization (a routine during right heart catheterization), but this is an invasive procedure that is seldom performed. A thermal movie of the external jugular vein at a specific neck position may help to measure the JVP. In this study different modalities of JVP assessment (clinical assessment, thermal image and invasive measurement) are to be compared Patients scheduled for right heart catheterization at the Shaare Zedek Medical Center for non-study related medical indications will be approached. Non-invasive estimates of JVP will be performed independently prior to the right heart catheterization, during the waiting period (within 2 hours) prior to catheterization. These will include up to 2min of thermal camera recording (to be analysed offline) and a physician's JVP evaluation. The angle of the patient's upper body will be 30-60°, the rotation of the neck will be optimal for filming, and the neck area may be cooled to enhance the images. Blinding to the results will be confirmed by performance with separate investigators and separate data registration. Right heart catheterization will then be performed and RA pressure will be recorded, as well as pulmonary and wedge pressures. JVP measured by physician and thermal image will be matched with invasive catheterization (the gold standard) using Bland Altman plots and Spearmann correlation and comparison between methods will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2017
CompletedFirst Submitted
Initial submission to the registry
November 21, 2019
CompletedFirst Posted
Study publicly available on registry
November 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedNovember 27, 2019
November 1, 2019
2.9 years
November 21, 2019
November 25, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
central venous pressure (direct and indirect evaluation)
comparison of estimated venous pressure (in mmHg) to the direct measurement during right heart catheterization
up to 30 days for analysis of the thermal images, up to 24hours for the direct measurement
Interventions
Thermal imaging of neck veins
Eligibility Criteria
Patients scheduled for right heart catheterization at the Shaare Zedek Medical Center for non-study related medical indications will be approached
You may qualify if:
- Patients already scheduled for right heart catheterization for clinical indication
- Age 18-90
You may not qualify if:
- Local scar wound or bruise in the right side of the neck.
- Current upper torso central venous catheterization such as a PICC line or dialysis catheter.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shaare zedek MC
Jerusalem, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tal Hasin, MD
SaareZMC
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2019
First Posted
November 27, 2019
Study Start
February 5, 2017
Primary Completion
December 30, 2019
Study Completion
December 31, 2019
Last Updated
November 27, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share